Renal Denervation Devices Market

Renal Denervation Devices play a major role in modern healthcare and are used in treatment of uncontrolled or persistent hypertension, where hypertensive medication is ineffective. The procedure consists of a catheter that emits radiofrequency energy across multiple electrodes.

Renal Denervation Devices Market contains market size and forecasts of Renal Denervation Devices in global, including the following market information:

• Global Renal Denervation Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Renal Denervation Devices Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Renal Denervation Devices companies in 2021 (%)

The global Renal Denervation Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

By Product Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Renal Denervation Devices include Medtronic Inc, Abbott Laboratories, Ablative Solutions, Inc, Mercator MedSystems, Inc, ReCor Medical, Inc, Boston Scientific Corp, Cordis Corporation, Terumo Corporation and Symple Surgical Inc. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Renal Denervation Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Renal Denervation Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Renal Denervation Devices Market Segment Percentages, by Type, 2021 (%)

By Product

• Simplicity Renal Denervation System
• EnligHTN Multi-Electrode Renal Denervation System
• Vessix Vascular (V2) Renal denervation System
• OneShot Renal Denervation System
• PARADISE (Percutaneous Renal Denervation System)
• Others

By Technology

• Renal Sympathetic Denervation Procedure
• Radiofrequency-based Renal Denervation Systems (RF-RDN)
• Ultrasound-based Renal Denervation Systems (US-RDN)
• Micro-infusion catheter-based Renal Denervation Systems

Global Renal Denervation Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Renal Denervation Devices Market Segment Percentages, by Application, 2021 (%)

• Diagnostic Centers and Hospitals
• Research & Academia
• Ambulatory Care Centers
• Others

Global Renal Denervation Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Renal Denervation Devices Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Renal Denervation Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Renal Denervation Devices revenues share in global market, 2021 (%)
• Key companies Renal Denervation Devices sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Renal Denervation Devices sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Medtronic Inc
• Abbott Laboratories
• Ablative Solutions, Inc
• Mercator MedSystems, Inc
• ReCor Medical, Inc
• Boston Scientific Corp
• Cordis Corporation
• Terumo Corporation
• Symple Surgical Inc